Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with Neuroblastoma

1 Oct 2004

Abstract excerpt

Currently, patients with neuroblastoma are classified into risk groups (e.g., according to the Children's Oncology Group risk-stratification) to guide physicians in the choice of the most appropriate therapy. Despite this careful stratification, the survival rate for patients with high-risk neuroblastoma remains <30%, and it is not possible to predict which of these high-risk patients will survive or succumb to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15466177
DOI: 10.1158/0008-5472.can-04-0695

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with NeuroblastomaPMID 15466177Read ↗

Artificial neural network classifier predicts neuroblastoma patients’ outcomeSemantic proximity Read ↗

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingSemantic proximity Read ↗

Clinically Relevant Biomarker Discovery in High-Risk Recurrent NeuroblastomaSemantic proximity Read ↗

Prognostic Impact of Gene Expression–Based Classification for NeuroblastomaSemantic proximity Read ↗

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk StratificationSemantic proximity Read ↗

Validation of a prognostic multi‐gene signature in high‐risk neuroblastoma using the high throughput digital NanoString nCounter™ systemSemantic proximity Read ↗

Bioinformatics identification of key genes associated with risk and prognosis of neuroblastomaSemantic proximity Read ↗

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaSemantic proximity Read ↗

Identification of novel prognostic markers of survival time in high-risk neuroblastoma using gene expression profilesSemantic proximity Read ↗

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomasSemantic proximity Read ↗

A Three-Gene Expression Signature Model for Risk Stratification of Patients with NeuroblastomaSemantic proximity Read ↗

Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.